• 1. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. Agricultural
  Analyst, 1947,72, 170-172
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099

Professional Introduction to 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid (CAS No. 234445-61-5)

2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 234445-61-5, is a significant compound in the realm of pharmaceutical and biochemical research. This heterocyclic organic compound belongs to the thiazole family, a class of molecules widely recognized for their diverse biological activities and utility in medicinal chemistry. The structural framework of 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid consists of a thiazole ring system substituted with a propyl group at the 2-position and a carboxylic acid moiety at the 4-position. Such structural features make it a versatile scaffold for further chemical modifications and functionalization, enabling its application in various synthetic pathways and drug discovery initiatives.

The thiazole core is a six-membered aromatic ring containing sulfur and nitrogen atoms at positions 1 and 3, respectively. This unique constitution imparts distinct electronic and steric properties to the molecule, influencing its interactions with biological targets. The presence of the propyl group at the 2-position introduces additional conformational flexibility, while the carboxylic acid functionality at the 4-position provides opportunities for salt formation, hydrogen bonding, and further derivatization. These characteristics have positioned 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid as a valuable intermediate in the synthesis of more complex pharmacophores.

In recent years, there has been growing interest in thiazole derivatives due to their broad spectrum of biological activities. Studies have demonstrated that compounds incorporating thiazole moieties exhibit potential in various therapeutic areas, including antimicrobial, anti-inflammatory, anticancer, and antiviral applications. The specific substitution pattern of 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid may contribute to its unique pharmacological profile, making it a promising candidate for further investigation.

One of the most compelling aspects of 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid is its utility as a building block in medicinal chemistry. Researchers have leveraged this compound to develop novel inhibitors targeting enzymes involved in metabolic pathways relevant to diseases such as diabetes and cancer. For instance, derivatives of thiazole have been explored as kinase inhibitors, where the propyl group and carboxylic acid moiety play critical roles in modulating binding affinity and selectivity. The carboxylic acid group can be further functionalized into esters or amides, expanding the chemical space available for structure-activity relationship (SAR) studies.

The synthesis of 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid typically involves multi-step organic reactions starting from commercially available precursors. Common synthetic routes include cyclization reactions to form the thiazole ring followed by alkylation and carboxylation steps to introduce the propyl and carboxylic acid functionalities. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for industrial applications. Techniques such as transition metal-catalyzed cross-coupling reactions have been particularly useful in constructing complex thiazole derivatives with high precision.

From a computational chemistry perspective, 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid has been subjected to extensive molecular modeling studies to elucidate its interactions with biological targets. Quantum mechanical calculations have provided insights into its electronic structure and reactivity patterns, aiding in the design of optimized derivatives. These computational approaches are complemented by experimental validations using spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), ensuring accurate structural characterization.

The pharmacological potential of 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid has been further explored through preclinical studies. In vitro assays have demonstrated inhibitory effects on enzymes such as carbonic anhydrase and proteases, which are implicated in various pathological conditions. Additionally, animal models have shown promising results regarding anti-inflammatory and analgesic properties. These findings underscore the compound's therapeutic relevance and justify its inclusion in ongoing drug development pipelines.

As research progresses, novel applications for 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid continue to emerge. Innovations in drug delivery systems have opened up possibilities for targeted therapies using this compound as an active pharmaceutical ingredient (API). Nanotechnology-based formulations have been investigated to enhance bioavailability and reduce side effects associated with traditional oral or injectable medications. Such advancements highlight the compound's adaptability across different domains of pharmaceutical science.

The environmental impact of synthesizing and utilizing 2-(propan-2-yl)-1,3-thiazole-4-carboxylic acid is also a consideration in modern research practices. Green chemistry principles are being integrated into synthetic protocols to minimize waste generation and energy consumption. Solvent-free reactions and catalytic methods are being explored as alternatives to conventional approaches. These efforts align with global initiatives aimed at sustainable pharmaceutical manufacturing.

In conclusion,(CAS No.) 23444561 5 plays a pivotal role in contemporary pharmaceutical research due to its structural versatility and biological significance。 As scientists continue to uncover new therapeutic applications，this compound is poised to remain at the forefront of drug discovery initiatives。 Its multifaceted utility underscores why it is such an important molecule for researchers worldwide。

• 35272-15-2(2-methylthiazole-4-carboxylic acid)
• 478366-05-1(2-cyclopropyl-1,3-thiazole-4-carboxylic acid)
• 923605-08-7(2-cyclohexyl-1,3-thiazole-4-carboxylic acid)
• 439905-17-6(2-(cyanomethyl)-1,3-thiazole-4-carboxylic acid)
• 769124-05-2(2-ethyl-1,3-thiazole-4-carboxylic acid)
• 13139-47-4(2-acetyl-1,3-thiazole-4-carboxylic acid)
• 955400-83-6(2-cyclopentyl-1,3-thiazole-4-carboxylic acid)
• 336193-96-5(Methyl 2-isopropylthiazole-4-carboxylate)
• 133047-44-6(Ethyl 2-isopropylthiazole-4-carboxylate)
• 133047-45-7(4-(Hydroxymethyl)-2-isopropylthiazole)